EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Understanding issues of driving safety and transport utilisation among clients receiving opioid agonist treatment: a cross-sectional survey in New South Wales, Australia

Daniel T Winter iD, Lauren A Monds, Nicholas Lintzeris, Benjamin C Riordan, Paul S Haber, Carolyn A Day

Australian Journal of Primary Health · 2025

DOI: 10.1071/py25035 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Australian Journal of Primary Health, 2025. Verfasst von Daniel T Winter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Automobile Driving, Analgesics, Opioid, Driving Under the Influence. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Barriers to accessing opioid agonist treatment (OAT) extend beyond regulatory and clinical constraints, with logistical factors such as clinic location, limited prescriber availability, and transport challenges also playing a role. Despite this, transport-related barriers remain underexplored in the literature. This study aims to examine transport practices and driving histories among OAT clients.

Methods

A cross-sectional survey across 15 public OAT clinics in New South Wales, Australia, was performed. Data were collected on participant demographics, sedating medication and illicit substance use, driving and other transport practices, and driving offence histories. Multivariate binary logistic regression examined factors associated with driving under the influence and reported driving offences.

Results

Of the 482 clients surveyed, 86.5% reported using sedating medications or illicit drugs in the past month, and 40.3% had driven within that period. Fifty-seven participants reported driving after using a potentially impairing substance in the last month, who were more likely to receive OAT from a private clinic or pharmacy (aOR = 2.37, 95% CI = 1.14–4.92) and report past month illicit drug use (aOR = 6.55, 95% CI = 2.89–14.83). Participants with recent driving offences were more likely male (aOR = 1.87, 95% CI = 1.11–3.13) and to have a history of a driver licence suspension (aOR = 8.95, 95% CI = 5.38–14.90).

Conclusions

Although substance use was common among participants, which could impact on driving safety, most did not report driving under the influence. A subset of clients who drive while impaired may present a public safety risk, and strategies to address this issue would be warranted. Ensuring appropriate access to OAT, including consideration of transport availability, remains a key component of equitable and safe treatment delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Related DisordersAutomobile DrivingAnalgesics, OpioidDriving Under the InfluenceTransportationOpiate Substitution TreatmentHumansCross-Sectional StudiesMaleNew South WalesFemaleAdultMiddle AgedSurveys and QuestionnairesYoung Adult

Stichwörter der Autor:innen

buprenorphinedriving safetydriving-related behavioursdrug drivingmethadoneopioid agonist treatmentopioid use disordertransporttreatment access

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Drug and Alcohol Services, Northern Sydney Local Health District, Sydney, NSW, Australia.
  • Edith Collins Centre (Translational Research Centre in Alcohol Drugs and Toxicology), Sydney Local Health District, Camperdown, NSW, Australia.
  • NSW Drug and Alcohol Clinical Research and Improvement Network (DACRIN), Sydney, NSW, Australia.
  • Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, NSW, Australia.
  • Centre for Alcohol Policy Research, La Trobe University, Melbourne, Vic, Australia.

ORCID-Profile: Daniel T Winter

Zitieren

APA

Winter, D. T., Monds, L. A., Lintzeris, N., Riordan, B. C., Haber, P. S., & Day, C. A. (2025). Understanding issues of driving safety and transport utilisation among clients receiving opioid agonist treatment: a cross-sectional survey in New South Wales, Australia. Australian Journal of Primary Health. https://doi.org/10.1071/py25035

Vancouver

Winter DT, Monds LA, Lintzeris N, Riordan BC, Haber PS, Day CA. Understanding issues of driving safety and transport utilisation among clients receiving opioid agonist treatment: a cross-sectional survey in New South Wales, Australia. Australian Journal of Primary Health. 2025. doi:10.1071/py25035

BibTeX
@article{Winter2025,
  author = {Winter, Daniel T and Monds, Lauren A and Lintzeris, Nicholas and Riordan, Benjamin C and Haber, Paul S and Day, Carolyn A},
  title = {Understanding issues of driving safety and transport utilisation among clients receiving opioid agonist treatment: a cross-sectional survey in New South Wales, Australia},
  journal = {Australian Journal of Primary Health},
  year = {2025},
  doi = {10.1071/py25035}
}
Kostenlos starten →